Stanford University: Rectal Neoplasms trials
The registry lists 10 Rectal Neoplasms studies with Stanford University as lead sponsor. 1 are open to participants now and 3 have results posted.
Phase 2 1No phase 9(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With CancerRecruitingNCT05297734Not applicable
- Organ Preservation Program Using Short-Course Radiation & FOLFOXIRI in Rectal CancerCompletedNCT04380337Phase 2Results posted
- Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With CancerCompletedNCT03154190Not applicableResults posted
- Engagement of Patients With Advanced CancerCompletedNCT02966509Not applicableResults posted
- Perfusion CT as a Predictor of Treatment Response in Patients With Rectal CancerCompletedNCT01460641
- Clinical and Pathologic Studies of Patients Undergoing Treatment With EGFR InhibitorsTerminatedNCT01137162
- Collection of Biospecimen & Clinical Information in Patients w/ Gastrointestinal CancersWithdrawnNCT01031056
- Avastin/[18-F]-5-fluorouracil PET/CT Imaging Feasibility ProjectCompletedNCT00661154
- Assessment of Health Related Quality of Life in Patients Treated for Rectal CancerTerminatedNCT00532987
- Metabolic Imaging Predict Histopathologic Response to Preop ChemoXRT for Locally Advanced Rectal CATerminatedNCT00394615Not applicable